GUIDED THERAPEUTICS INC (GTHP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 1.5M 3M 4.5M FY10: 3.4M FY11: 3.6M FY12: 3.3M FY13: 820K FY14: 65K FY15: 42K FY16: 0 FY17: 244K FY18: 57K FY19: 36K FY20: 102K FY21: 81K FY22: 13K FY23: 98K FY24: 7K FY25: 767K FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-400K -200K 0 200K 400K 600K FY11: -81K FY12: -45K FY13: -252K FY14: -133K FY15: 27K FY16: 112K FY17: -286K FY18: -32K FY19: -34K FY20: 143K FY21: 20K FY22: -68K FY23: 36K FY24: 2K FY25: 571K FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-9M -6M -3M 0 3M 6M 9M FY10: -1.6M FY11: -6.8M FY12: -4.3M FY13: -6.6M FY14: -8.7M FY15: -6.2M FY16: -3.8M FY17: -3.1M FY18: -1.5M FY19: -937K FY20: -1.1M FY21: -2.4M FY22: -3.3M FY23: -3.5M FY24: -2.1M FY25: -2.4M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-12M -8M -4M 0 4M 8M 12M FY10: -2.8M FY11: -6.6M FY12: -4.4M FY13: -7.2M FY14: -9.9M FY15: -6.9M FY16: -4M FY17: -10.7M FY18: 1M FY19: -1.9M FY20: -279K FY21: -2.1M FY22: -4.3M FY23: -3.5M FY24: -2.4M FY25: -3.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

-200K 0 200K 400K 600K FY10: 0 FY11: -106K FY17: 530K FY18: 89K FY19: 70K FY20: -41K FY21: 61K FY22: 81K FY23: 62K FY24: 5K FY25: 196K FY10 FY11 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY16: -1.8M FY17: -1.1M FY18: -1.4M FY19: -806K FY20: -1.9M FY21: -1.6M FY22: -1.5M FY23: -1.7M FY24: -1.1M FY25: -1.1M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY16: -1.8M FY19: -806K FY20: -1.9M FY21: -1.6M FY22: -1.5M FY23: -1.7M FY24: -1.1M FY25: -1.1M FY16 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 30M 60M 90M FY10: 38.6K FY11: 48.9K FY12: 57.4K FY13: 65.9K FY14: 771 FY15: 2 FY16: 203 FY17: 0 FY18: 65.2K FY19: 3.3K FY20: 10.8K FY21: 13.4M FY22: 32.5M FY23: 51.1M FY24: 57.3M FY25: 78.4M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.21 -0.14 -0.07 0.00 0.07 0.14 0.21 Q4 '21: -0.17 Q1 '22: -0.18 Q2 '22: -0.13 Q3 '22: -0.16 Q4 '22: -0.16 Q1 '25: -0.05 Q2 '25: -0.05 Q3 '25: -0.05 Q4 '25: -0.04 Q1 '26: -0.04 Q2 '26: -0.04 Q4 '21 Q2 '22 Q4 '22 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.